Protocol No.: WVU010922

Prospective Evaluation of Xerava (Eravacycline) Prophylaxis in Hematological Malignancy Patients with Prolonged Neutropenia
Principal Investigator
Cumpston, Aaron
Phase
II
Age Group
Adult
Applicable Disease Sites
Leukemia
Lymphoma
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kathryn Oliverio, LPN
Research Specialist
Phone: +1 304-293-7374

View on ClinicalTrials.gov